Mariner
THC icon

Mariner’s Tenet Healthcare THC Stock Holding History

Mariner’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.26M Sell
33,477
-18,497
-36% -$3.4M 0.01% 942
2026
Q1 		$9.81M Sell
51,974
-3,978
-7% -$838K 0.01% 760
2025
Q4 		$11.1M Buy
55,952
+26,584
+91% +$5.37M 0.01% 660
2025
Q3 		$5.96M Buy
29,368
+11,810
+67% +$2.1M 0.01% 856
2025
Q2 		$3.09M Buy
17,558
+6,585
+60% +$991K ﹤0.01% 1091
2025
Q1 		$1.48M Buy
10,973
+2,369
+28% +$312K ﹤0.01% 1411
2024
Q4 		$1.09M Buy
8,604
+1,697
+25% +$252K ﹤0.01% 1586
2024
Q3 		$1.15M Buy
6,907
+417
+6% +$63.1K ﹤0.01% 1502
2024
Q2 		$863K Sell
6,490
-804
-11% -$96.8K ﹤0.01% 1620
2024
Q1 		$767K Buy
7,294
+842
+13% +$75.7K ﹤0.01% 1706
2023
Q4 		$488K Sell
6,452
-319
-5% -$20.2K ﹤0.01% 1944
2023
Q3 		$446K Buy
6,771
+332
+5% +$24.8K ﹤0.01% 1855
2023
Q2 		$524K Sell
6,439
-671
-9% -$47.8K ﹤0.01% 1704
2023
Q1 		$422K Buy
7,110
+695
+11% +$38.6K ﹤0.01% 1791
2022
Q4 		$313K Sell
6,415
-2,003
-24% -$92.6K ﹤0.01% 1995
2022
Q3 		$434K Buy
+8,418
New +$500K ﹤0.01% 1501

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Mariner's THC Position: Q2 2026 in Review

Mariner reduced its Tenet Healthcare (THC) stake by 36% in Q2 2026, selling an estimated $3.4M and leaving 33,477 shares worth $6.26M. The position accounts for 0.01% of the portfolio, ranked #942.

Mariner first reported a position in THC in Q3 2022 and has held it in 16 quarters since. The position peaked at $11.1M in Q4 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Mariner held 33,477 shares of Tenet Healthcare worth $6.26M as of Q2 2026.
  • Mariner sold 18,497 Tenet Healthcare shares in Q2 2026, an estimated $3.4M.
  • Tenet Healthcare made up 0.01% of Mariner's portfolio in Q2 2026, its #942 holding.
  • Mariner first reported a position in Tenet Healthcare in Q3 2022 and has held it in 16 quarters since.
  • Mariner's Tenet Healthcare position peaked at $11.1M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.